COLOCORT

Post-LOE

hydrocortisone

Molecular Devices

ANDARECTALENEMA

Approved

Dec 1999

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

COLOCORT (hydrocortisone) by Molecular Devices is corticosteroid hormone receptor agonists [moa]. Approved for ulcerative colitis. First approved in 1999.

Drug data last refreshed 21h ago

Mechanism of Action

Corticosteroid Hormone Receptor Agonists

Pharmacologic Class:

Corticosteroid

Indications (1)

ulcerative colitis

Clinical Trials (20)

NCT07262957Phase 4Recruiting

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Started Sep 2025

400 enrolled

Pancreas Head CancerPancreas AdenocarcinomaIPMN, Pancreatic+7 more

NCT06895473Phase 2Recruiting

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Started Jun 2025

26 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT05354778N/ARecruiting

HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Started Oct 2022

180 enrolled

Healthcare-Associated PneumoniaVentilator Associated Pneumonia

NCT05063994Phase 3Completed

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

Started May 2022

55 enrolled

Congenital Adrenal Hyperplasia

NCT05159284Phase 4Recruiting

Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction

Started Nov 2021

Worked on COLOCORT at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.